Bellevue Asset Management (Switzerland)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	$8.43M	Sell	67,000 -15,500	-19%	-$1.95M	1.28%	27
2015 Q3	$8.59M	Sell	82,500 -6,000	-7%	-$625K	1.4%	18
2015 Q2	$10.9M	Sell	88,500 -5,000	-5%	-$617K	1.52%	17
2015 Q1	$11M	Buy	+93,500	New	+$11M	1.54%	17